Brainstorm Cell Therapeutics Inc (BCLI)
0.38
0.00 (0.00%)
USD |
NASDAQ |
May 07, 09:34
Brainstorm Cell Therapeutics Free Cash Flow: -20.48M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -20.48M |
| September 30, 2023 | -21.84M |
| June 30, 2023 | -20.26M |
| March 31, 2023 | -19.64M |
| December 31, 2022 | -19.35M |
| September 30, 2022 | -20.24M |
| June 30, 2022 | -22.09M |
| March 31, 2022 | -21.29M |
| December 31, 2021 | -26.60M |
| September 30, 2021 | -28.86M |
| June 30, 2021 | -29.18M |
| March 31, 2021 | -29.53M |
| December 31, 2020 | -35.57M |
| September 30, 2020 | -31.38M |
| June 30, 2020 | -28.10M |
| March 31, 2020 | -25.92M |
| December 31, 2019 | -11.72M |
| September 30, 2019 | -11.93M |
| June 30, 2019 | -14.79M |
| March 31, 2019 | -11.42M |
| December 31, 2018 | -12.76M |
| September 30, 2018 | -11.92M |
| June 30, 2018 | -1.571M |
| March 31, 2018 | -3.073M |
| December 31, 2017 | -2.544M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.75M |
| June 30, 2017 | -4.793M |
| March 31, 2017 | -4.596M |
| December 31, 2016 | -5.961M |
| September 30, 2016 | -6.066M |
| June 30, 2016 | -8.322M |
| March 31, 2016 | -8.523M |
| December 31, 2015 | -7.453M |
| September 30, 2015 | -8.219M |
| June 30, 2015 | -6.796M |
| March 31, 2015 | -6.10M |
| December 31, 2014 | -4.648M |
| September 30, 2014 | -4.193M |
| June 30, 2014 | -3.818M |
| March 31, 2014 | -3.957M |
| December 31, 2013 | -4.162M |
| September 30, 2013 | -3.254M |
| June 30, 2013 | -3.598M |
| March 31, 2013 | -2.917M |
| December 31, 2012 | -3.025M |
| September 30, 2012 | -2.795M |
| June 30, 2012 | -2.605M |
| March 31, 2012 | -2.977M |
| December 31, 2011 | -2.271M |
| September 30, 2011 | -2.339M |
Free Cash Flow Range, Past 5 Years
-35.57M
Minimum
Dec 2020
-11.72M
Maximum
Dec 2019
-23.09M
Average
-21.84M
Median
Sep 2023
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.285M |
| Cash from Investing (Quarterly) | 0.196M |
| Cash from Financing (Quarterly) | 3.352M |
| Free Cash Flow Per Share (Quarterly) | -0.0637 |
| Free Cash Flow Yield | -125.2% |